STEPS: A Virtual Reality-based Intervention for Adults With Autism.
STEPS
STEPS (Social Cognitive Training Enhancing Pro-functional Skills): A Clinical Randomized Trial Evaluating the Effect of a Virtual Reality-based Intervention for Adults With Autism.
1 other identifier
interventional
140
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a new Virtual Reality-based intervention will be effective in treating social cognitive challenges in adults with autism. The main questions it aims to answer are:
- 1.Is Virtual Reality-based social cognitive training effective in reducing social cognitive deficits and improving psychosocial functioning, quality of life, and clinical symptoms in adults with ASD?
- 2.Is Virtual Reality-based social cognitive training cost-effective?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2024
CompletedFirst Submitted
Initial submission to the registry
May 23, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
June 3, 2024
May 1, 2024
2.2 years
May 23, 2024
May 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Social Responsiveness Scale, Adult Version, Self-report
The primary outcome is level of social impairment is measured by the Social Responsiveness Scale, Second Edition, Adult version, Self-report (SRS-2A) at cessation of treatment at 3-months. SRS-2A measures the presence and severity of social impairment in everyday life. The SRS-2A is a commonly used measure in autism spectrum research and has demonstrated good reliability and validity. SRS-2A is a 65-item rating scale, scored on on a 4-point Likert Scale (0-3). Each item is scaled from 0 (never true) to 3 (almost always true), generating a total score ranging from 0 to 195. The SRS-2A is provides a continuous measure of social impairment, where a higher score reflects a greater degree of difficulties with social interactions in everyday life. Follow-up assessments will comprise ratings of the previous two-week period.
Baseline, 3 month follow-up and 6 month follow-up
Secondary Outcomes (5)
Social Responsiveness Scale, Adult Version, Informant Report
Baseline, 3 month follow-up and 6 month follow-up
Social Interaction Anxiety Scale (SIAS)
Baseline, 3 month follow-up and 6 month follow-up
The Empathy Quotient
Baseline, 3 month follow-up and 6 month follow-up
The High Risk Social Challenge Task (HiSoC)
Baseline, 3 month follow-up and 6 month follow-up
Emotion Recognition Task (CANTAB ERT)
Baseline, 3 month follow-up and 6 month follow-up
Other Outcomes (25)
CAT-Q (Camouflaging Autistic Traits Questionnaire)
Baseline, 3 month follow-up and 6 month follow-up
SR-AS (Questionnaire on sensory reactions)
Baseline, 3 month follow-up and 6 month follow-up
Beck Depression Inventory (BDI)
Baseline, 3 month follow-up and 6 month follow-up
- +22 more other outcomes
Study Arms (2)
Virtual Reality-based Social Cognitive Training (VRSCT)
EXPERIMENTALPatients in the experimental group will be offered 10 individual sessions of targeted, virtual reality assisted psychotherapy embedded in cognitive behavioral therapy (CBT), that aims at enhancing social cognition and daily life functioning. If the patient consents, two additional sessions will be offered in which the patient's relatives are invited to participate (one in the beginning of treatment and one at the end of treatment). The aim of the relative involvement is to enhance transfer from the therapy to the patients daily life. The treatment will be conducted by psychologists with an extensive knowledge in providing virtual reality assisted therapy. The treatment is manualized, and the therapists will receive ongoing supervision by a senior clinician having ≥ 25 years of experience in conducting assessment, treatment, and research with the autism spectrum population.
Treatment as Usual (TAU)
NO INTERVENTIONThe treatment-as-usual (TAU) group will receive the standard treatment offered to adults diagnosed with ASD in Denmark. This commonly consists of four psychoeducational sessions as well as limited supportive counseling. Some adults with ASD also receive practical help in daily life situations in community settings. The TAU will be mapped upon trial completion.
Interventions
Virtual reality assisted social cognitive training embedded in cognitive behavioral therapy, that aims at enhancing social cognition and daily life functioning.
Eligibility Criteria
You may qualify if:
- Age of 18 years or older
- Ability to give informed consent
- Diagnosis of an autism spectrum disorder (ICD-10 code F84.0; F84.1; F84.5; F84.8)
- T-score on SRS-A self-report ≥ 60
You may not qualify if:
- Rejecting informed consent
- A diagnosis of organic brain disease
- Intellectual disability (IQ ˂ 70)
- A command of spoken Danish or English inadequate for engaging in therapy
- ADHD-diagnosis with untreated symptoms
- Displaying an imminent homicidal or suicidal risk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhagen Research Centre for Mental Health (CORE), Mental Health Centre Copenhagen, Mental Health Services in the Capital Region, Denmark
Copenhagen, Hellerup, 2900, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louise B. Glenthøj, DrMSc
Copenhagen Research Centre for Mental Health (CORE), Mental Health Centre Copenhagen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Stratified block randomization with concealed randomization sequences will be conducted after baseline assessment. Independent assessors blinded to the treatment will evaluate outcomes. Analysis of outcomes will be carried out following the intention-to-treat principles.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DMSc, PhD, psychologist with specialization in psychiatry and specialist in psychotherapy
Study Record Dates
First Submitted
May 23, 2024
First Posted
June 3, 2024
Study Start
May 2, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
June 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share